AntiviralsLipohypertrophy and acquired resistance: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2025年 / 2043卷 / 1期

关键词：

D O I：

10.1007/s40278-025-75331-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：50 / 50

相关论文

共 50 条

[21] AmikacinTreatment failure due to acquired resistance: 3 case reports
Reactions Weekly, 2015, 1555 (1) : 20 - 20
[22] OsimertinibAcquired resistance and acquired genetic alterations: 49 case reports
Reactions Weekly, 2025, 2047 (1) : 364 - 364
[23] AntiviralsVirological failure secondary to acquired resistance: 9 case reports
Reactions Weekly, 2020, 1808 (1) : 57 - 57
[24] VismodegibDevelopment of primary and acquired resistance in basal cell carcinoma and disease progression: 2 case reports
Reactions Weekly, 2015, 1539 (1) : 290 - 290
[25] Multiple drugsDrug intolerance, cytopenias, acquired drug resistance and lack of efficacy: 2 case reports
Reactions Weekly, 2025, 2046 (1) : 313 - 313
[26] TemozolomideVitiligo and acquired drug resistance following off-label use: 2 case reports
Reactions Weekly, 2020, 1815 (1) : 297 - 297
[27] AntineoplasticsMyelotoxicity, acquired drug resistance and lack of efficacy: 4 case reports
Reactions Weekly, 2020, 1818 (1) : 40 - 40
[28] Erlotinib/gefitinibTreatment failure and development of acquired resistance : 18 case reports
Reactions Weekly, 2021, 1852 (1) : 187 - 187
[29] EntecavirLack of drug effect and acquired drug resistance: 15 case reports
Reactions Weekly, 2021, 1886 (1) : 182 - 182
[30] Multiple drugsWorsening leg oedema and acquired resistance: 7 case reports
Reactions Weekly, 2022, 1899 (1) : 293 - 293

← 1 2 3 4 5 →